October 10, 2012
Renowned Breast Cancer Researcher Presents Blass Lecture
The late philanthropist Elizabeth Weitzenhoffer “Betsy” Blass believed in the power of knowledge and research. She also was passionate about her volunteer involvement at the University of Arkansas for Medical Sciences (UAMS).
June 15, 2010
Learn How Our Researchers Are Unraveling The Genetics Behind Myeloma
<p style=”margin-top: auto; margin-right: 0in; margin-bottom: auto; margin-left: 0in;”>Learn how our researchers are unraveling the genetics behind Myeloma.</p>
December 13, 2007
UAMS Hosts Tribute for Myeloma Survivors
Jeff Glanz, of Broken Arrow, Okla., was 35 years old with two young children when he was diagnosed with multiple myeloma.
October 10, 2007
Shaughnessy Group Myeloma Research Gets Scientific Boost
It often takes years for scientific findings to advance from the lab to the patient’s bedside, often because of the need for independent verification of those findings.
September 18, 2007
MIRT Work Presented at National Cancer Research Conference
<span style=”font-size: 12pt; font-family: arial;”><span style=”font-size: 13px;”>Multiple myeloma patients vary widely in how they ultimately respond to treatment, but now researchers in the </span><a href=”http://myeloma.uams.edu/”><span style=”font-size: 13px;”>Myeloma Institute for Research and Therapy</span></a><span style=”font-size: 13px;”> (MIRT) at the University of Arkansas for Medical Sciences (UAMS) in Little Rock, Ark., have identified a small subset of genes whose level of activation could predict low and </span><a href=”http://www.uams.edu/update/absolutenm/templates/myeloma/myeloma_news.asp?articleid=6220&zoneid=132″><span style=”font-size: 13px;”>high-risk cases</span></a><span style=”font-size: 13px;”> and potentially guide their therapy in the future.</span></span>
August 13, 2007
Potential Therapeutic Targets Identified in Multiple Myeloma
<span>Researchers have identified molecular changes in multiple myeloma cells that activate an important biological pathway associated with cell growth and survival, thereby revealing potential new targets for drugs to treat this cancer. The researchers, led by a team from the National Cancer Institute (NCI), part of the National Institutes of Health, have shown that malignant cells in multiple myeloma frequently harbor mutations that activate what is called the NF-kappaB signaling pathway, which plays a key role in promoting cell growth and preventing programmed cell death. The results of this research appear in the August, 2007, issue of Cancer Cell.</span>
April 2, 2007
Myeloma Researchers Find New Tool for Identifying High-Risk Cases
A genetic analysis model developed by researchers at the University of Arkansas for Medical Sciences (UAMS) has outperformed all current clinical tests for identifying patients with aggressive multiple myeloma, a cancer of the bone marrow.
April 10, 2006
Myeloma Researcher On Team Analyzing Disease’s Genetic Fingerprints
<span style=”font-size: 13px;”>Researchers at the Myeloma Institute for Research and Therapy (MIRT) are part of a team that has identified that </span><a href=”http://myeloma.uams.edu/”><span style=”font-size: 13px;”>multiple myeloma</span></a><span style=”font-size: 13px;”>, a cancer of the blood, could actually be several different diseases at the molecular level with a potential for genetically targeted treatments that could extend to other forms of cancer.</span>